Digestive Endoscopy Unit, Fondazione Policlinico Universitario "A. Gemelli", Rome, Italy.
Division of Gastroenterology, Mayo Clinic School of Medicine, Scottsdale, Arizona.
Clin Gastroenterol Hepatol. 2016 Nov;14(11):1533-1543.e8. doi: 10.1016/j.cgh.2016.04.038. Epub 2016 May 7.
BACKGROUND & AIMS: Colon capsule endoscopy (CCE) is a noninvasive technique used to explore the colon without sedation or air insufflation. A second-generation capsule was recently developed to improve accuracy of detection, and clinical use has expanded globally. We performed a systematic review and meta-analysis to assess the accuracy of CCE in detecting colorectal polyps. METHODS: We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and other databases from 1966 through 2015 for studies that compared accuracy of colonoscopy with histologic evaluation with CCE. The risk of bias within each study was ascertained according to Quality Assessment of Diagnostic Accuracy in Systematic Reviews recommendations. Per-patient accuracy values were calculated for polyps, overall and for first-generation (CCE-1) and second-generation (CCE-2) capsules. We analyzed data by using forest plots, the I statistic to calculate heterogeneity, and meta-regression analyses. RESULTS: Fourteen studies provided data from 2420 patients (1128 for CCE-1 and 1292 for CCE-2). CCE-2 and CCE-1 detected polyps >6 mm with 86% sensitivity (95% confidence interval [CI], 82%-89%) and 58% sensitivity (95% CI, 44%-70%), respectively, and 88.1% specificity (95% CI, 74.2%-95.0%) and 85.7% specificity (95% CI, 80.2%-90.0%), respectively. CCE-2 and CCE-1 detected polyps >10 mm with 87% sensitivity (95% CI, 81%-91%) and 54% sensitivity (95% CI, 29%-77%), respectively, and 95.3% specificity (95% CI, 91.5%-97.5%) and 97.4% specificity (95% CI, 96.0%-98.3%), respectively. CCE-2 identified all 11 invasive cancers detected by colonoscopy. CONCLUSIONS: The sensitivity in detection of polyps >6 mm and >10 mm increased substantially between development of first-generation and second-generation colon capsules. High specificity values for detection of polyps by CCE-2 seem to be achievable with a 10-mm cutoff and in a screening setting.
背景与目的:结肠胶囊内镜(CCE)是一种非侵入性技术,用于在不镇静或不充气的情况下探查结肠。最近开发了第二代胶囊以提高检测准确性,并且其临床应用已经在全球范围内扩展。我们进行了一项系统评价和荟萃分析,以评估 CCE 在检测结直肠息肉中的准确性。
方法:我们从 1966 年到 2015 年在 MEDLINE、EMBASE、Cochrane 对照试验中心注册库和其他数据库中搜索了比较结肠镜检查与 CCE 组织学评估准确性的研究。根据系统评价中诊断准确性质量评估的建议,确定每个研究的偏倚风险。为息肉、总体以及第一代(CCE-1)和第二代(CCE-2)胶囊计算了每位患者的准确性值。我们通过森林图、I ²统计量计算异质性和荟萃回归分析来分析数据。
结果:14 项研究提供了来自 2420 名患者的数据(CCE-1 为 1128 名,CCE-2 为 1292 名)。CCE-2 和 CCE-1 检测 >6mm 的息肉的敏感性分别为 86%(95%置信区间[CI],82%-89%)和 58%(95%CI,44%-70%),特异性分别为 88.1%(95%CI,74.2%-95.0%)和 85.7%(95%CI,80.2%-90.0%)。CCE-2 和 CCE-1 检测 >10mm 的息肉的敏感性分别为 87%(95%CI,81%-91%)和 54%(95%CI,29%-77%),特异性分别为 95.3%(95%CI,91.5%-97.5%)和 97.4%(95%CI,96.0%-98.3%)。CCE-2 发现了结肠镜检查发现的所有 11 例侵袭性癌症。
结论:第一代和第二代结肠胶囊的发展使 >6mm 和 >10mm 息肉的检测敏感性有了显著提高。CCE-2 检测息肉的高特异性值似乎可以通过 10mm 截止值和筛查设置来实现。
Clin Gastroenterol Hepatol. 2016-5-7
Cochrane Database Syst Rev. 2018-8-15
Cochrane Database Syst Rev. 2022-6-6
Lancet Gastroenterol Hepatol. 2024-11
Health Technol Assess. 2010-6
Clin Gastroenterol Hepatol. 2010-3-6
Cochrane Database Syst Rev. 2012-1-18
Ther Adv Gastrointest Endosc. 2025-8-30
Therap Adv Gastroenterol. 2024-7-23
Diagnostics (Basel). 2024-2-20
Therap Adv Gastroenterol. 2023-10-9
Curr Gastroenterol Rep. 2023-5
J Gastroenterol Hepatol. 2022-12
Diagnostics (Basel). 2022-8-29
Diagnostics (Basel). 2022-8-17